To view this email as a web page, click here.
Conference Coverage
 
 September 17, 2018
 
EADV 2018 wrapped in Paris on Sunday. Visit our conference page for our news reports from Paris.
 
Surgical treatment for basal cell carcinomas still the best bet
There are many non-surgical treatments for basal cell carcinomas, but a physician reporting at EADV last week said new treatments should be compared against surgery, which has the highest cure rate and lowest rate of recurrence.
 
Treating moles and melanoma during pregnancy
A pregnancy-associated melanoma (PAM) prognosis does not appear to be worse than melanoma in non-pregnant controls, researchers reported at EADV. Nonetheless, measures should be taken to protect the fetus in the treatment and imaging of PAM.
 
Combination therapies may be best for tattoo removal
EADV report summarizes the latest advances in laser technology for tattoo removal.
 
A review of treatment for dermatofibrosarcoma
Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.
 
Two opposing views on how best to treat actinic keratosis
Is it just a “spot” or precancerous lesion? Two physicians debate how best to treat actinic keratosis in a talk given at EADV last week.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.